FDA records a banner year in new-drug approvals, with 41
Roughly 40% are for rare diseases; PD-1 oncolytics capture industry attention
With acquisition of OptumHealth assets, Mapi Group bids to capture health economics consulting work globally
Mapi Group casts itself as a leading 'health research and commercialization' player
Doximity crosses 50% line of engagement with physician population
'Stay tuned' for interactions directly with pharma companies, says CEO Jeff Tangney
Walgreens-Alliance Boots tie-up is formally approved
So long WAG, hello to WBA as pharma manufacturers look at a consolidating buyer landscape
Nurses remain the top most trusted profession, says annual Gallup poll
Pharmacists' ranking, continuing a two-year decline, is now neck-and-neck with doctors
Hepatitis C therapies multiply and price concessions appear behind the scenes
Express Scripts touts a 'fundamental change' in drug pricing; others would call it negotiating a discount
Dohmen acquires Siren Interactive, a rare diseases agency
Acquisition builds on Dohmen's rare-disease business
UPS Healthcare Logistics picks up an asset in Poland
Poltraf acquisition adds to a network of 14 facilities serving Eastern and Western Europe
Drug pricing debate is sharpening
Will formularies become a consumer's concern for healthcare provision?
The Chief Compliance Officer role
DSCSA dominates HDMA Distribution Management Annual Conference
The broad changes taking place in the pharma supply chain this year are a relevant focus for the annual conference and exhibition
Industry traceability activity ramps up, with some companies already preparing for 2017
FDA enforcement delay to May 1 isn't slowing down project work
Is BioLife Solutions cornering the market for handling human cells and tissues?
Company hires Kevin O'Donnell, cold chain expert, to build out its Biologistex shipping service
Data security for Pharma
Cloud computing opens a new array of benefits--and challenges--to data-sharing
Data and identity security basics
Identity Management
The quality improvement drive to address drug shortages
Persistent drug shortages are mostly attributable to manufacturing quality problems, but the economics of low-margin generic manufacturing challenge the industry
Managing government pricing programs
When state and federal governments are involved, prices and reimbursements have both regulatory and financial consequences
The evolving CSO landscape
Outsourced field sales is becoming only part of what CSOs are offering their pharma clients
A conversation with Phil Hagerman, Diplomat Pharmacy
Veeva, Cegedim announce new partnerships and IT alliances in pharma sales force automation
Publicis Touchpoint Solutions does a deal with Cegedim Relationship Management
Managing third-party risks in the life sciences industry
Internal compliance reviews are not enough; life sciences companies need to assess their third-party business partners
The Price of Global Health
Defining 'market access'
Practice Fusion EHR and OPTIMIZERx team up to expand sample, coupon access
Compliance issues around sampling will be featured at upcoming conference
